Company Overview
Snapshot
Founded in October 2022, Hemico Imaging operates with 1–10 employees. The company has secured funding across one round from one investor. In March 2023, Hemico Imaging received Pre-Seed funding from NGT HealthCare II.
Business overview
Hemico Imaging develops the I-arm, a light and compact medical imaging system designed to be operated by surgeons with minimal effort. This technology aims to reduce radiation exposure tenfold for both radiography and fluoroscopy, while also offering a smaller footprint compared to traditional C-arm devices, thereby saving space in operating rooms. The company operates within the Health Tech & Life Sciences sector, specifically focusing on medical equipment for the healthcare industry.
Company Intelligence Q&A
- What is Hemico Imaging's primary product?
- Hemico Imaging develops the I-arm, a light and compact medical imaging system designed for radiography and fluoroscopy with reduced radiation exposure and a smaller footprint in operating rooms.
- When was Hemico Imaging founded?
- Hemico Imaging was founded in October 2022.
- What is the current operational status of Hemico Imaging?
- Hemico Imaging is currently non-active and ceased to operate in September 2025.
- Which investor participated in Hemico Imaging's funding round?
- In March 2023, Hemico Imaging received Pre-Seed funding from NGT HealthCare II.
- In which sector does Hemico Imaging primarily operate?
- Hemico Imaging operates in the Health Tech & Life Sciences sector, focusing on medical devices and equipment.